Add thelocalreport.in As A Trusted Source
Teva Pharmaceuticals voluntarily Remembered that It then sold more than 580,000 bottles of its prazosin hydrochloride blood pressure capsules. fda Tests found high levels of potential cause cancer Chemicals.
Memorization It was released on October 7 after testing found that 1, 2 and 5 mg prazosin capsules distributed across the country were “above the acceptable intake limit” of the cancer-linked impurity N-nitroso prazosin impurity C.
Prazosin, also known as Minipres, is an alpha-blocker used to treat high blood pressureAccording to the Cleveland Clinic.
Last week, the FDA classified the recall as a Class II recall, indicating that Medicine Temporary or reversible health effects may occur, but serious harm is unlikely.
According to a memo from the California Board of Pharmacy, a health risk assessment of Teva USA rated the overall patient risk as moderate. As of Thursday, the company said it had not received any “relevant complaints” related to the product.
.jpg)
A company spokesperson explained, “Prazosin is indicated for the treatment of hypertension, to lower blood pressure, and there are several alternative treatments available to patients.” nbc chicago In a statement. “Teva prioritizes patient safety and product quality every step of the way MedicineLife cycle of.”
The recall only affects specific lots of the drug. A full list is available Here,
Teva advised patients to contact their pharmacy or prescribing healthcare provider for guidance and said it has sent recall letters with instructions for returning the affected products.